To the issue of spontaneous oncogenetic transformation of pluripotent mesenchymal stromal stem cells
- Authors: Bersenev A.V.
- Issue: Vol 2, No 1 (2007)
- Pages: 9-10
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/181646
- ID: 181646
Cite item
Full Text
About the authors
A. V. Bersenev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Caplan A.I., Dennis J.E.Mesenchymal stem cells as trophic mediators. J. Cell Biochem. 2006; 98(5): 1076-84.
- Caplan A.I., Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. T rends Mol. Med. 2001; 7(6): 259-64.
- http://www.osiristx.com/clinical_trials.php.
- Riggi N., Cironi L., Provero P. et al. Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 2006; 65: 11459-68.
- Rubio D., Garcia-Castro J., Martin MC, de la Fuente R. et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65(8): 3035-9.
- Miura M., Miura Y., Padilla-Nash H.M. et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stemcells leads to malignant transformation. Stem Cells 2006; 24(4): 1095-103.
- Wang Y., Huso D.L., Harrington J. et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005; 7(6): 509-19.
- Tolar J., Nauta A.J., Osborn M.J. et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25(2): 371-9.
- Dominici M., Le Blanc K., Mueller I. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-7.